Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The serum concentration of erythropoietin in 79 cases with various blood diseases, uremia, chronic obstructive pulmonary disease etc was determined. At comparable degrees of anemia, patients with myelodysplastic syndrome and aplastic anemia had the highest levels of erythropoietin in our study. The high level of erythropoietin titer in patients with aplastic anemia should be taken as the nom for renal synthesis and release of this hormone. The erythropoietin level in patients with uremic anemia was lower than the level in patients with anemia of other causes but still higher than that of the normal controls. Patients suffering from polycystic kidney disease with or without uremia had a high level of erythropoietin due to local hypoxia of remnant kidney tissue resulting from the pressure of cystic formation. Different methods are used to determine the erythropoietin level, which varies with the stage and etiology of the diseases. There are other stimulating or inhibitory factors of erythropoiesis when the assay is processed. Transfusion and administration of certain drugs also influence the growth of erythroid cells, thus the serum titers of erythropoietin differed markedly between patients at comparable hemoglobin concentration.
Zhonghua Nei Ke Za Zhi 1991 Jul
PMID:[The difference of erythropoietin concentration in various disease]. 175 56

The authors compared bone marrow histological changes in 28 cases of myelodysplastic syndrome (MDS), 21 cases of aplastic anemia and 8 cases of hemolytic anemia. It is shown that abnormal localization of immature precursors (ALIP) is a characteristic change in MDS. The presence of erythroblastic islands and the variance of morphology of megakaryocytes are valuable for diagnosis. The histological method for the observation of lymphoid micromegakaryocytes is not so accurate as cytological method. "ALIP" can more or less help to evaluate the prognosis of MDS. According to the histological changes, it is easy to differentiate the three types of anemia we studied.
Zhonghua Nei Ke Za Zhi 1991 Nov
PMID:[Bone marrow histological changes in myelodysplastic syndrome and its clinical significance]. 181 70

Ten cases of multiple myeloma seen in PUMC hospital survived more than six years. 4 of them survived more than ten years. 6 patients were of IgA type. Features of those cases included: (1) symptoms mild; (2) incidence of anemia low; (3) percentage of tumor cell in bone marrow also relatively low; (4) blood urea nitrogen, creatinine and calcium normal; (5) maintenance therapy rather long. The prognostic factors and the current general situation of treatment were briefly discussed.
Zhonghua Nei Ke Za Zhi 1991 Dec
PMID:[Report of 10 cases of multiple myeloma surviving more than 6 years]. 181 84

Erythrocyte basic ferritin (EF) concentration was determined in 64 normal subjects, 123 patients with anemia and 12 patients with leukopenia and thrombocytopenia. There was a significant difference between males and females. Other iron indices, including plasma iron (PI), total iron binding capacity (TIBC), zinc protoporphyrin (ZnPP) and plasma ferritin (PF) were also determined in all the subjects and bone marrow iron stain was determined in the 135 patients. The lowest EF concentration was seen in patients with iron deficiency anemia, being significantly lower than that in normal subjects. EF concentration in patients with iron deficiency erythropoiesis was also lower than that in normal subjects and at the same time significantly different from that in patients with iron deficiency anemia. EF concentration increased prior to PF concentration in patients with iron deficiency anemia who had been treated for a period of 1-8 weeks. EF concentration in patients with anemia of chronic diseases had a significant difference as compared with that in normal subjects and in patients with iron deficiency anemia, but EF concentration in those patients who were accompanied by iron deficiency was similar to that in patients with simple iron deficiency anemia. EF concentration in some iron overloaded patients (aplastic anemia, megaloblastic anemia, MDS etc.) was significantly higher than that in normal subjects. It was demonstrated that there was a good correlation between EF concentration and bone marrow sideroblastic iron in the rank correlation analysis of the iron indices in 135 patients (rs 0.893, P less than 0.01). PF concentration had the best correlation with marrow iron (rs 0.948, P less than 0.01).
Zhonghua Nei Ke Za Zhi 1990 Oct
PMID:[Evaluation of erythrocyte basic ferritin in the diagnosis of anemia]. 208

The determination of serum AchrA in patients with SLE(43) and other rheumatic diseases (ODRs, 109) and in 42 normal individuals was measured by indirect immunofluorescence assay (IIF) using the polytene chromosomes of the third instar larva of Drosophila melanogaster as the substrate. The results showed that the serum AchrA was negative in all of the 42 normal individuals and the 109 patients with ORDs and the AchrA was positive in 19 (44%) of the patients with SLE. The patients with active SLE were found in 16 (84%) of the 19 AchrA positive group and 13 (54%) of the 24 AchrA negative group. The incidence of arthritis/arthralgia, photosensitivity, glomerulonephritis and anemia in the SLE patients were higher in the AchrA positive group than those in the AchrA negative group. In contrast, the patients with nephrotic syndrome were more common in the AchrA negative group than in the AchrA positive group. It is suggested that serum AchrA is extremely specific and more sensitive for SLE and that the finding of positive AchrA are usually associated with activity of SLE and renal involvement.
Zhonghua Nei Ke Za Zhi 1990 Oct
PMID:[Serum anti-polytene chromosomes of Drosophila melanogaster antibody (AchrA) and systemic lupus erythematosus]. 212 58

Basing on the analysis of five tests including serum ferritin, erythrocyte protoporphyrin, serum iron, total iron binding capacity and transferrin saturation in 92 anemic patients who were classified into iron deficient anemia (IDA) and non-iron deficient anemia by their bone marrow iron status, three models of combination of tests were designed by varying the test combination and diagnostic levels in model 1 and 2 and multiple regression analysis in model 3. The sensitivity and specificity for IDA were 93.7% and 93.1% respectively with the optimum scheme of combination of tests from model 2 in which serum ferritin has more weight than other tests. With the optimum scheme from the model 3 which was the discriminant function, the sensitivity and specificity were 93.3% and 100% respectively when the scheme tests the cases who are not included in the calculation of the function. It will decrease the number of false-positive or false-negative diagnosis due to the complex results of combination of test when the optimum combination of tests is used in the investigation of iron status and clinical work.
Zhonghua Nei Ke Za Zhi 1989 Mar
PMID:[Diagnosis of iron deficiency anemia with an optimum combination of tests]. 280 48

Glucagonoma is a rare pancreatic tumor, necrolytic migratory erythema is its distinctive feature and it is often associated with diabetes mellitus, weight loss, anemia, hypoaminoacidemia, glossitis and stomatitis. We reported a case of glucagonoma misdiagnosed as "eczema" and "benign hepatic anginoma" for 3 years. His blood glucagon level was 1,758 ng/L. The results of abdominal B-mode ultrasonography and CT scan were negative, but selected arteriogram showed a tumor mass between the pancreatic body and tail. Before operation, treatment with octreotide and supply of amino acids were given with improvement of the skin lesion. After resection of the tumor from pancreas, necrolytic migratory erythema disapeared, but his blood level of glucagon and amino acids did not improve. It is suggested that any diabetic patient with chronic skin damage should be checked for blood glucagon level. In suspected cases, selected arteriogram will be helpful for location of the tumor. Vigorous resection of the pancreatic tumor should be done as soon as possible, even though there is already metastases.
Zhonghua Nei Ke Za Zhi 1995 Mar
PMID:[Report of a case of glucagonoma misdiagnosed as "eczema" and "hepatic angioma" for three years and review of literature]. 764 42

Castleman's disease (CD) is a chronic lymphoproliferative disorder characterized by presence of giant lymphoid masses. The clinical features and histopathologic findings of 8 cases of CD diagnosed according to the criteria described by Frizzera were reported. 2 were male and 6 female; their age ranged from 26-66 years. Four patients with localized CD (three with hyaline vascular type and one with mixed type) had no systemic symptoms and had survived for a long time after surgery. Four patients with multicentric CD developed anemia, fever, elevated ESR, polyclonal immunoglobulinemia and manifestations of multisystem involvement. Steroids, chemotherapy, and radiotherapy had only resulted in partial remission in multicentric CD. The clinicopathologic differential diagnosis of CD from reactive lymph node hyperplasia in chronic infections, malignant lymphoma, connective tissue disease and angio-immunoblastic lymphadenopathy and the pathogenesis of CD were discussed.
Zhonghua Nei Ke Za Zhi 1994 Mar
PMID:[A clinicopathological study of 8 cases of Castleman's disease]. 780 26

Anemia is one of the serious complications of chronic renal failure, therapy with recombinant human erythropoietin (r-HuEPO) can correct such anemia officiently. For most patients, the initial dose of r-HuEPO is 100U/kg, by intravenously or subcutaneous, three times a week. After 6 weeks of treatment, Hb could increase to 100g/L, and Hct to above 0.33-0.35. Then 500/kg 3 time a week can be used as maintaining dose. 4 patients need maintaining dose of 150U/kg, for pulmonary infection, poor nutrition, and poor iron supply. Therefore, during the treatment, iron folie acid and Vit B12 should be applied sufficiently and treat the infection effectively with the increasing of Hb and Hct, 2/3 of the patients have hypertension which can be controlled with medication. If there is thrombosis in the dialyzer, the dose of heparin should be increased. The patients on r-HuEPO should be dialysised sufficiently to prevent hyperkalemia.
Zhonghua Nei Ke Za Zhi 1994 Feb
PMID:[The observation of therapy of anemia in chronic renal failure with recombinant human erythropoietin]. 807 Feb 95

Subcutaneous (s.c.) administration of recombinant human erythropoietin (rHuEPO) has been proven to be effective in anemia of predialysis patients with chronic renal failure (CRF). However, the optimal dosage and frequency of administration have not been established. We use low dose (< 100U.kg-1.w-1) of s.c. rHuEPO to treat renal anemia in two groups (group A: n = 18, twice a week; group B; n = 14, once a week) of nondialytic CRF patients. Hb and Hct gradually increased 1-3 months aftes rHuEPO treatment in the two groups. The incidence of hypertension, one of the main side effects, was lower (4/18 in Group A, 4/14 in Group B) than that reported in the literature. These results showed that either twice weekly or once weekly s.c. injection of low dose rHuEPO is effective and there will be less side effects treating predialysis patients with CRF.
Zhonghua Nei Ke Za Zhi 1993 Jul
PMID:[The effect of low doses of recombinant human erythropoietin on renal anemia in predialysis patients with chronic renal failure]. 827 19


1 2 Next >>